NextPlat Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw record gross margins and a sharp reduction in operating losses, driven by healthcare segment profitability and cost controls. Nationwide expansion and new e-commerce initiatives are underway, with a strong cash position and no meaningful debt.
-
Shareholders approved an amendment allowing the board to execute reverse stock splits at a ratio of 1-for-5 up to 1-for-50 before March 27, 2028. Adjournment was unnecessary as sufficient votes were secured. Final results will be disclosed in a Form 8-K.
Fiscal Year 2025
-
Revenue declined 18% year-over-year to $54 million in 2025, but cost reductions and a strategic shift to higher margin healthcare and e-commerce services improved margins and set the stage for profitability in 2026. Nationwide healthcare expansion and strong cash position support growth.
-
Q3 2025 saw an 11% revenue decline year-over-year, but operational improvements and cost reductions began to take effect, with pharmacy and e-commerce segments showing late-quarter momentum. The company expects stronger results in Q4 and targets operational break-even in 2026.
-
Revenue declined year-over-year due to healthcare segment weakness, but e-commerce showed growth in recurring airtime and hardware sales. Cost reductions and operational improvements are underway, with a focus on healthcare and new business initiatives.
-
Q1 2025 revenue declined to $14.5M, mainly due to healthcare segment pressures, while e-commerce recurring airtime revenue grew 51% year-over-year. Tariffs delayed the Florida Sunshine launch in China, and strategic alternatives are being evaluated to maximize shareholder value.
Fiscal Year 2024
-
2024 saw strong revenue growth, driven by healthcare outperformance and e-commerce expansion, despite margin pressures and non-recurring costs. Strategic acquisitions and new contracts position the business for further growth, with a focus on efficiency and international markets.